标题
Spontaneous regression of neuroblastoma
作者
关键词
Neuroblastoma, Regression, Spontaneous, TrkA, Telomerase
出版物
CELL AND TISSUE RESEARCH
Volume 372, Issue 2, Pages 277-286
出版商
Springer Nature
发表日期
2018-01-05
DOI
10.1007/s00441-017-2761-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model
- (2016) Radhika Iyer et al. CANCER LETTERS
- Infantile Fibrosarcoma WithNTRK3-ETV6Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2016) Ramamoorthy Nagasubramanian et al. PEDIATRIC BLOOD & CANCER
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2015) R. C. Doebele et al. Cancer Discovery
- TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts
- (2014) Jamie L. Croucher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- EZH2 as a potential target in cancer therapy
- (2014) Michael T McCabe et al. Epigenomics
- Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma
- (2013) E. Barbieri et al. CANCER RESEARCH
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants
- (2012) Jed G. Nuchtern et al. ANNALS OF SURGERY
- DNA methylation inhibitors in cancer: Recent and future approaches
- (2012) Christina Gros et al. BIOCHIMIE
- AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts
- (2012) Radhika Iyer et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant
- (2012) M. Samy et al. MOLECULAR CANCER THERAPEUTICS
- Neonatal neuroblastoma
- (2012) Jonathan P.H. Fisher et al. Seminars in Fetal & Neonatal Medicine
- Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma
- (2012) Denis Andrew Cozzi et al. WORLD JOURNAL OF SURGERY
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
- (2011) Jane E. Minturn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The effect of P75 on Trk receptors in neuroblastomas
- (2011) Ruth Ho et al. CANCER LETTERS
- Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings
- (2011) Anneleen Decock et al. Epigenetics
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma
- (2011) Fang Yu et al. JOURNAL OF PEDIATRIC SURGERY
- Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma
- (2010) R. Iyer et al. CLINICAL CANCER RESEARCH
- Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients
- (2010) E. Grau et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not
- (2010) Vassiliki Nikoletopoulou et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
- (2010) David L. Baker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dependence receptors: a new paradigm in cell signaling and cancer therapy
- (2010) D Goldschneider et al. ONCOGENE
- Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
- (2009) Cinzia Lavarino et al. BMC CANCER
- On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- (2009) C. J. Thiele et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
- (2008) Jean Bénard et al. Molecular Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More